Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors: a meta-analysis

被引:0
|
作者
Wei, W.
Jiang, J.
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Peoples R China
[2] Jiangsu Engn Res Ctr Tumor Immunotherapy, Changzhou, Peoples R China
[3] Soochow Univ, Inst Cell Therapy, Changzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P3068
引用
收藏
页码:1583 / 1583
页数:1
相关论文
共 50 条
  • [1] Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors A meta-analysis
    Wei, Wei
    Xu, Bin
    Wang, Yan
    Wu, Chen
    Jiang, Jingting
    Wu, Changping
    MEDICINE, 2018, 97 (03)
  • [2] The Prognostic Value of Circulating Soluble Programmed Death Ligand-1 in Cancers: A Meta-Analysis
    Huang, Pei
    Hu, Wei
    Zhu, Ying
    Wu, Yushen
    Lin, Huapeng
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [3] Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis
    Kim, Hye Min
    Lee, Jinae
    Koo, Ja Seung
    BMC CANCER, 2017, 17
  • [4] Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis
    Hye Min Kim
    Jinae Lee
    Ja Seung Koo
    BMC Cancer, 17
  • [5] Meta-analysis of the prognostic value of soluble programmed death ligand-1 (sPD-L1) in cancers
    Sun, Jinfan
    Hu, Shuenqin
    Li, Xiuying
    BIOMARKERS, 2023, 28 (06) : 477 - 485
  • [6] Prognostic significance of programmed death ligand-1 immunohistochemical expression in esophageal cancer: A meta-analysis of the literature
    Yu, Weiwei
    Guo, Yanmei
    MEDICINE, 2018, 97 (30)
  • [7] Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis
    Saleh, Ramy R.
    Scott, Jordan L.
    Meti, Nicholas
    Perlon, Danielle
    Fazelzad, Rouhi
    Ocana, Alberto
    Amir, Eitan
    MOLECULAR DIAGNOSIS & THERAPY, 2022, 26 (02) : 153 - 168
  • [8] Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis
    Ramy R. Saleh
    Jordan L. Scott
    Nicholas Meti
    Danielle Perlon
    Rouhi Fazelzad
    Alberto Ocana
    Eitan Amir
    Molecular Diagnosis & Therapy, 2022, 26 : 153 - 168
  • [9] The Prognostic Significance of Soluble Programmed Death Ligand 1 Expression in Cancers: A Systematic Review and Meta-analysis
    Ding, Y.
    Sun, C.
    Li, J.
    Hu, L.
    Li, M.
    Liu, J.
    Pu, L.
    Xiong, S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (05) : 361 - 367
  • [10] Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis
    Guo, Yawen
    Yu, Pan
    Liu, Zeming
    Maimaiti, Yusufu
    Wang, Shan
    Yin, Xingjie
    Liu, Chunping
    Huang, Tao
    PLOS ONE, 2016, 11 (05):